Balyasny Asset Management »

Soleno Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $10M 247k 40.80
2024-03-31 $6.5M 152k 42.80
2023-12-31 $37M 927k 40.25
2023-09-30 $14M 459k 29.51

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Nantahala Capital Management
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Commodore Capital
State Street Corporation
Alyeska Investment Group
Sofinnova Ventures
Frazier Life Sciences Management
Vestal Point Capital
Holocene Advisors

View all funds holding Soleno Therapeutics